Synthesis, luminescent properties and antibacterial activity of new pyrazoline and pyrimidine derivatives of (2e)-1-biphenyl-3-arylprop-2-en-1-ones
- Autores: Isakhanyan A.U.1, Hakobyan N.Z.1, Hovasyan Z.A.1, Grigoryan G.S.2, Mkhitaryan R.P.1, Aracelyan H.G.1, Safaryan A.S.1, Muradyan R.E.1, Panosyan H.A.1
-
Afiliações:
- Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
- Yerevan State University
- Edição: Volume 93, Nº 9 (2023)
- Páginas: 1335-1342
- Seção: Articles
- URL: https://cardiosomatics.ru/0044-460X/article/view/667311
- DOI: https://doi.org/10.31857/S0044460X23090032
- EDN: https://elibrary.ru/WWNIDR
- ID: 667311
Citar
Resumo
Palavras-chave
Sobre autores
A. Isakhanyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
Email: anush.isakhanyan.51@mail.ru
N. Hakobyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
Z. Hovasyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
G. Grigoryan
Yerevan State University
R. Mkhitaryan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
H. Aracelyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
A. Safaryan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
R. Muradyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
H. Panosyan
Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia
Bibliografia
- Li J.-T., Zhang X.-H., Lin Z.-P. // Beilstein J. Org. Chem. 2007. Vol. 3. N 13. doi: 10.1186/1860-5397-3-13
- Li Q.S., Shen B.N., Zhang Z., Luo S., Ruan B.F. // Curr. Med. Chem. 2021. Vol. 28. N 5. P. 940. doi: 10.2174/0929867327666200306120151
- Patil S.B. // Int. J. Pharm. Sci. Res. 2018. Vol. 9. N 1. P. 44. doi: 10.13040/IJPSR.0975-8232.9(1).44-52
- Elkanzi N.A.A. // Orient. J. Chem. 2020. Vol. 36. N 6. P. 1001. doi: 10.13005/ojc/360602
- Sviripa V.M., Zhang W., Balia A.G., Tsodikov O.V., Nickell J.R., Gizard F., Yu T., Lee E.Y., Dwoskin L.P., Watt D.S. // J. Med. Chem. 2014. Vol. 57. P. 6083. doi: 10.1021/jm5004864
- Varghese B., Al-Busafi S.N., Suliman F.O., AlKindy S.M.Z. // RSC Adv. 2017. Vol. 7. P. 46999. doi: 10.1039/C7RA08939B
- Selivanova D.G., Gorbunov A.A., Mayorova O.A., Vasyanin A.N., Lunegov I.V., Shklyaeva E.V., Abashev G.G. // Beilstein J. Org. Chem. 2017. Vol. 13. P. 1583. doi: 10.3762/bjoc.13.158.
- Achelle S., Rodríguez-Lopez J., Larbani M., Plaza-Pedroche R., Robin-le Guen F. // Molecules. 2019. Vol. 24. P. 1742. doi: 10.3390/molecules24091742
- Shivananda M.K., Holla B.S. // J. Chem. Pharm. Res. 2017. Vol. 9. N 6. P. 1.
- Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Медицина, 2012. С. 509.
- Машковский М.Д. Лекарственные средства. М.: Новая волна, 2010. С. 851.
Arquivos suplementares
